Cleared Traditional

K050648 - SOVEREIGN HIGH VACUUM PACK, SOVEREIGN COMPACT HIGH VACUUM PACK

K050648 is an FDA 510(k) clearance for SOVEREIGN HIGH VACUUM PACK, manufactured by Advanced Medical Optics, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 22-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2005
Decision
22d
Days
Class 2
Risk

K050648 is an FDA 510(k) clearance for the SOVEREIGN HIGH VACUUM PACK, SOVEREIGN COMPACT HIGH VACUUM PACK. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Advanced Medical Optics, Inc. (Santa Ana, US). The FDA issued a Cleared decision on April 5, 2005 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Advanced Medical Optics, Inc. devices

FDA 510(k) Submission Details - K050648

510(k) Number K050648 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 14, 2005
Decision Date April 05, 2005
Days to Decision 22 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 110d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 166
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K050648.
BAUSCH & LOMB D4600A AIR EXCHANGE LINE PACK
K082132 · Bausch & Lomb, Inc. · Aug 2008
STERILS SINGLE-USE I/A HANDPIECES
K073023 · Bausch & Lomb, Inc. · Mar 2008
BAUSCH & LOMB NGX MICROSURGICAL SYSTEM
K063331 · Bausch & Lomb, Inc. · Dec 2006
PHACO CHOP NEEDLES
K041998 · Bausch & Lomb, Inc. · Aug 2004
VENTURI PHACO PACK
K033653 · Bausch & Lomb, Inc. · Dec 2003
INFINITI
K021566 · Alcon Laboratories, Inc. · Jul 2002